Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 452, Issue 4, 2014, Pages 928-932

  Tsuchiya, Mai ^a   Nakajima, Yuka ^a   Hirata, Naoya ^b   Morishita, Tamaki ^a   Kishimoto, Hiroyuki ^a   Kanda, Yasunari ^b   Kimura, Keiji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Breast cancer; Cancer stem cell; CHIP

Indexed keywords

CARBOXYL TERMINUS OF HSC70 INTERACTING PROTEIN; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; STUB1 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; BREAST TUMOR; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; FEMALE; MCF 7 CELL LINE; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMANS; MCF-7 CELLS; NEOPLASTIC STEM CELLS; UBIQUITIN-PROTEIN LIGASES;

EID: 84907907479     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.011     Document Type: Article

References (36)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in: GLOBOCAN 2008 Int. J. Cancer 127 2010 2008 2893 2917
2. M. Kajiro, R. Hirota, Y. Nakajima, K. Kawanowa, K. So-ma, I. Ito, Y. Yamaguchi, S.H. Ohie, Y. Kobayashi, Y. Seino, M. Kawano, Y. Kawabe, H. Takei, S. Hayashi, M. Kurosumi, A. Murayama, K. Kimura, and J. Yanagisawa The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways Nat. Cell Biol. 11 2009 312 319
3. C.A. Ballinger, P. Connell, Y. Wu, Z. Hu, L.J. Thompson, L.Y. Yin, and C. Patterson Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions Mol. Cell. Biol. 19 1999 4535 4545
4. H. McDonough, and C. Patterson CHIP: a link between the chaperone and proteasome systems Cell Stress Chaperones 8 2003 303 308
5. J. Jiang, C.A. Ballinger, Y. Wu, Q. Dai, D.M. Cyr, J. Hohfeld, and C. Patterson CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation J. Biol. Chem. 276 2001 42938 42944
6. S. Murata, Y. Minami, M. Minami, T. Chiba, and K. Tanaka CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein EMBO Rep. 2 2001 1133 1138
7. A.L. Goldberg Protein degradation and protection against misfolded or damaged proteins Nature 426 2003 895 899
8. L. Li, H. Xin, X. Xu, M. Huang, X. Zhang, Y. Chen, S. Zhang, X.Y. Fu, and Z. Chang CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription Mol. Cell. Biol. 24 2004 856 864
9. A. Lazorchak, M.E. Jones, and Y. Zhuang New insights into E-protein function in lymphocyte development Trends Immunol. 26 2005 334 338
10. C.H. Woo, N.T. Le, T. Shishido, E. Chang, H. Lee, K.S. Heo, D.M. Mickelsen, Y. Lu, C. McClain, T. Spangenberg, C. Yan, C.A. Molina, J. Yang, C. Patterson, and J. Abe Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor FASEB J. 24 2010 4917 4928
11. N. Patani, W. Jiang, R. Newbold, and K. Mokbel Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer J. Carcinog. 9 2010 9
12. R.J. Jones Cancer stem cells-clinical relevance J. Mol. Med. (Berlin) 87 2009 1105 1110
13. K. Eppert, K. Takenaka, E.R. Lechman, L. Waldron, B. Nilsson, P. van Galen, K.H. Metzeler, A. Poeppl, V. Ling, J. Beyene, A.J. Canty, J.S. Danska, S.K. Bohlander, C. Buske, M.D. Minden, T.R. Golub, I. Jurisica, B.L. Ebert, and J.E. Dick Stem cell gene expression programs influence clinical outcome in human leukemia Nat. Med. 17 2011 1086 1093
14. M. Al-Hajj, and M.F. Clarke Self-renewal and solid tumor stem cells Oncogene 23 2004 7274 7282
15. F. Li, B. Tiede, J. Massague, and Y. Kang Beyond tumorigenesis: cancer stem cells in metastasis Cell Res. 17 2007 3 14
16. J.E. Visvader, and G.J. Lindeman Cancer stem cells: current status and evolving complexities Cell Stem Cell 10 2012 717 728
17. M. Dean ABC transporters, drug resistance, and cancer stem cells J. Mammary Gland Biol. Neoplasia 14 2009 3 9
18. E.M.F. De Sousa, L. Vermeulen, E. Fessler, and J.P. Medema Cancer heterogeneity - a multifaceted view EMBO Rep. 14 2013 686 695
19. M. Cariati, A. Naderi, J.P. Brown, M.J. Smalley, S.E. Pinder, C. Caldas, and A.D. Purushotham Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line Int. J. Cancer 122 2008 298 304
20. C. Wu, and B.A. Alman Side population cells in human cancers Cancer Lett. 268 2008 1 9
21. Y. Glinka, N. Mohammed, V. Subramaniam, S. Jothy, and G.J. Prud'homme Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-kappaB activation and tumor sphere formation Biochem. Biophys. Res. Commun. 425 2012 775 780
22. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 100 2003 3983 3988
23. M.H. Wright, A.M. Calcagno, C.D. Salcido, M.D. Carlson, S.V. Ambudkar, and L. Varticovski Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics Breast Cancer Res. 10 2008 R10
24. M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R.H. Datar, and R.J. Cote Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin. Cancer Res. 12 2006 5615 5621
25. L. Patrawala, T. Calhoun, R. Schneider-Broussard, J. Zhou, K. Claypool, and D.G. Tang Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic Cancer Res. 65 2005 6207 6219
26. T. Chiba, K. Kita, Y.W. Zheng, O. Yokosuka, H. Saisho, A. Iwama, H. Nakauchi, and H. Taniguchi Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties Hepatology 44 2006 240 251
27. P.P. Szotek, R. Pieretti-Vanmarcke, P.T. Masiakos, D.M. Dinulescu, D. Connolly, R. Foster, D. Dombkowski, F. Preffer, D.T. Maclaughlin, and P.K. Donahoe Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness Proc. Natl. Acad. Sci. U.S.A. 103 2006 11154 11159
28. M.M. Ho, A.V. Ng, S. Lam, and J.Y. Hung Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells Cancer Res. 67 2007 4827 4833
29. C.R. Jeter, B. Liu, X. Liu, X. Chen, C. Liu, T. Calhoun-Davis, J. Repass, H. Zaehres, J.J. Shen, and D.G. Tang NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation Oncogene 30 2011 3833 3845
30. J.X. Cheng, B.L. Liu, and X. Zhang How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat. Rev. 35 2009 403 408
31. F. Yu, J. Li, H. Chen, J. Fu, S. Ray, S. Huang, H. Zheng, and W. Ai Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion Oncogene 30 2011 2161 2172
32. J. Yang, D. Liao, C. Chen, Y. Liu, T.H. Chuang, R. Xiang, D. Markowitz, R.A. Reisfeld, and Y. Luo Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway Stem Cells 31 2013 248 258
33. C. Ginestier, S. Liu, M.E. Diebel, H. Korkaya, M. Luo, M. Brown, J. Wicinski, O. Cabaud, E. Charafe-Jauffret, D. Birnbaum, J.L. Guan, G. Dontu, and M.S. Wicha CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts J. Clin. Invest. 120 2010 485 497
34. M.P. Ablett, C.S. O'Brien, A.H. Sims, G. Farnie, and R.B. Clarke A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity Oncotarget 5 2014 599 612
35. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 8 2008 755 768
36. G.K. Malhotra, X. Zhao, H. Band, and V. Band Shared signaling pathways in normal and breast cancer stem cells J. Carcinog. 10 2011 38